Arseneault L.

Cannon M.

Poulton R.

Murray R.

Caspi A.

Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ. 325 : 1212-1213 View in Article PubMed

Crossref

Google Scholar

Zammit S.

Allebeck P.

Andreasson S.

Lundberg I.

Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. BMJ. 325 : 1199-1204 View in Article PubMed

Crossref

Google Scholar

Giordano G.N.

Ohlsson H.

Sundquist K.

Sundquist J.

Kendler K.S. The association between cannabis abuse and subsequent schizophrenia: A Swedish national co-relative control study. Psychol Med. 3 : 1-8 View in Article Google Scholar

Compton M.T.

Kelley M.E.

Ramsay C.E.

Pringle M.

Goulding S.M.

Esterberg M.L.

et al. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am J Psychiatry. 166 : 1251-1257 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Veen N.D.

Selten J.P.

van der Tweel I.

Feller W.G.

Hoek H.W.

Kahn R.S. Cannabis use and age at onset of schizophrenia. Am J Psychiatry. 161 : 501-506 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Di Forti M.

Sallis H.

Allegri F.

Trotta A.

Ferraro L.

Stilo S.A.

et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 40 : 1509-1517 View in Article Scopus (65)

PubMed

Crossref

Google Scholar

Manrique-Garcia E.

Zammit S.

Dalman C.

Hemmingsson T.

Andreasson S.

Allebeck P. Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol Med. 44 : 2513-2521 View in Article Scopus (12)

PubMed

Crossref

Google Scholar

Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry. 67 : 3-8 View in Article PubMed

Google Scholar

Lisdahl K.M.

Gilbart E.R.

Wright N.E.

Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. 4 : 53 View in Article Scopus (61)

PubMed

Crossref

Google Scholar

Meier M.H.

Caspi A.

Ambler A.

Harrington H.

Houts R.

Keefe R.S.

et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 109 : E2657-E2664 View in Article Scopus (356)

PubMed

Crossref

Google Scholar

Yucel M.

Bora E.

Lubman D.I.

Solowij N.

Brewer W.J.

Cotton S.M.

et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull. 38 : 316-330 View in Article Scopus (88)

PubMed

Crossref

Google Scholar

Schneider M.

Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology. 28 : 1760-1769 View in Article Scopus (235)

PubMed

Crossref

Google Scholar

O’Shea M.

Singh M.E.

McGregor I.S.

Mallet P.E. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol. 18 : 502-508 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Quinn H.R.

Matsumoto I.

Callaghan P.D.

Long L.E.

Arnold J.C.

Gunasekaran N.

et al. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 33 : 1113-1126 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Verrico C.D.

Gu H.

Peterson M.L.

Sampson A.R.

Lewis D.A. Repeated delta9-tetrahydrocannabinol exposure in adolescent monkeys: Persistent effects selective for spatial working memory. Am J Psychiatry. 171 : 416-425 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Glantz L.A.

Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 57 : 65-73 View in Article PubMed

Crossref

Google Scholar

Kolluri N.

Sun Z.

Sampson A.R.

Lewis D.A. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry. 162 : 1200-1202 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Hashimoto T.

Volk D.W.

Eggan S.M.

Mirnics K.

Pierri J.N.

Sun Z.

et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 23 : 6315-6326 View in Article PubMed

Crossref

Google Scholar

Fung S.J.

Webster M.J.

Sivagnanasundaram S.

Duncan C.

Elashoff M.

Weickert C.S. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry. 167 : 1479-1488 View in Article Scopus (142)

PubMed

Crossref

Google Scholar

Volk D.W.

Matsubara T.

Li S.

Sengupta E.J.

Georgiev D.

Minabe Y.

et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry. 169 : 1082-1091 View in Article Scopus (63)

PubMed

Crossref

Google Scholar

Akbarian S.

Kim J.J.

Potkin S.G.

Hagman J.O.

Tafazzoli A.

Bunney Jr, W.E.

Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52 : 258-266 View in Article PubMed

Crossref

Google Scholar

Volk D.W.

Austin M.C.

Pierri J.N.

Sampson A.R.

Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 57 : 237-245 View in Article PubMed

Crossref

Google Scholar

Guidotti A.

Auta J.

Davis J.M.

Gerevini V.D.

Dwivedi Y.

Grayson D.R.

et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 57 : 1061-1069 View in Article PubMed

Crossref

Google Scholar

Straub R.E.

Lipska B.K.

Egan M.F.

Goldberg T.E.

Callicott J.H.

Mayhew M.B.

et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 12 : 854-869 View in Article Scopus (175)

PubMed

Crossref

Google Scholar

Curley A.A.

Arion D.

Volk D.W.

Asafu-Adjei J.K.

Sampson A.R.

Fish K.N.

Lewis D.A. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: Clinical, protein, and cell type-specific features. Am J Psychiatry. 168 : 921-929 View in Article Scopus (113)

PubMed

Crossref

Google Scholar

Cho R.Y.

Konecky R.O.

Carter C.S. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A. 103 : 19878-19883 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Minzenberg M.J.

Firl A.J.

Yoon J.H.

Gomes G.C.

Reinking C.

Carter C.S. Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology. 35 : 2590-2599 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Eggan S.M.

Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis. Cereb Cortex. 17 : 175-191 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Eggan S.M.

Melchitzky D.S.

Sesack S.R.

Fish K.N.

Lewis D.A. Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience. 169 : 1651-1661 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Katona I.

Sperlagh B.

Sik A.

Kafalvi A.

Vizi E.S.

Mackie K.

Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci. 19 : 4544-4558 View in Article PubMed

Crossref

Google Scholar

Katona I.

Rancz E.A.

Acsady L.

Ledent C.

Mackie K.

Hajos N.

Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci. 21 : 9506-9518 View in Article PubMed

Crossref

Google Scholar

Pertwee R.G.

Howlett A.C.

Abood M.E.

Alexander S.P.

Di Marzo V.

Elphick M.R.

et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB(1) and CB(2). Pharmacol Rev. 62 : 588-631 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Hashimotodani Y.

Ohno-Shosaku T.

Kano M. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci. 27 : 1211-1219 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Bisogno T.

Howell F.

Williams G.

Minassi A.

Cascio M.G.

Ligresti A.

et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol. 163 : 463-468 View in Article Scopus (595)

PubMed

Crossref

Google Scholar

Yoshida T.

Fukaya M.

Uchigashima M.

Miura E.

Kamiya H.

Kano M.

Watanabe M. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci. 26 : 4740-4751 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Ludanyi A.

Hu S.S.

Yamazaki M.

Tanimura A.

Piomelli D.

Watanabe M.

et al. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience. 174 : 50-63 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Yoshida T.

Uchigashima M.

Yamasaki M.

Katona I.

Yamazaki M.

Sakimura K.

et al. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci U S A. 108 : 3059-3064 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Szabo B.

Urbanski M.J.

Bisogno T.

Di M.V.

Mendiguren A.

Baer W.U.

Freiman I. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol. 577 : 263-280 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Uchigashima M.

Narushima M.

Fukaya M.

Katona I.

Kano M.

Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci. 27 : 3663-3676 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Dinh T.P.

Carpenter D.

Leslie F.M.

Freund T.F.

Katona I.

Sensi S.L.

et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A. 99 : 10819-10824 View in Article Scopus (817)

PubMed

Crossref

Google Scholar

Marrs W.R.

Blankman J.L.

Horne E.A.

Thomazeau A.

Lin Y.H.

Coy J.

et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci. 13 : 951-957 View in Article Scopus (211)

PubMed

Crossref

Google Scholar

Gulyas A.I.

Cravatt B.F.

Bracey M.H.

Dinh T.P.

Piomelli D.

Boscia F.

Freund T.F. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 20 : 441-458 View in Article Scopus (251)

PubMed

Crossref

Google Scholar

Bluett R.J.

Gamble-George J.C.

Hermanson D.J.

Hartley N.D.

Marnett L.J.

Patel S. Central anandamide deficiency predicts stress-induced anxiety: Behavioral reversal through endocannabinoid augmentation. Transl Psychiatry. 4 : e408 View in Article PubMed

Crossref

Google Scholar

Brown J.A.

Horvath S.

Garbett K.A.

Schmidt M.J.

Everheart M.

Gellert L.

et al. The role of cannabinoid 1 receptor expressing interneurons in behavior. Neurobiol Dis. 63 : 210-221 View in Article PubMed

Crossref

Google Scholar

Giuffrida A.

Leweke F.M.

Gerth C.W.

Schreiber D.

Koethe D.

Faulhaber J.

et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology. 29 : 2108-2114 View in Article Scopus (267)

PubMed

Crossref

Google Scholar

Koethe D.

Giuffrida A.

Schreiber D.

Hellmich M.

Schultze-Lutter F.

Ruhrmann S.

et al. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. Br J Psychiatry. 194 : 371-372 View in Article Scopus (73)

PubMed

Crossref

Google Scholar

De Marchi N.

De Petrocellis L.

Orlando P.

Daniele F.

Fezza F.

Di Marzo V. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis. 2 : 5 View in Article PubMed

Crossref

Google Scholar

Leweke F.M.

Giuffrida A.

Wurster U.

Emrich H.M.

Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 10 : 1665-1669 View in Article PubMed

Crossref

Google Scholar

Palkovits M.

Harvey-White J.

Liu J.

Kovacs Z.S.

Bobest M.

Lovas G.

et al. Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. Neuroscience. 152 : 1032-1039 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Volk D.W.

Eggan S.M.

Lewis D.A. Alterations in metabotropic glutamate receptor 1alpha and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry. 167 : 1489-1498 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Dean B.

Sundram S.

Bradbury R.

Scarr E.

Copolov D. Studies on [3H]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience. 103 : 9-15 View in Article Scopus (272)

PubMed

Crossref

Google Scholar

Zavitsanou K.

Garrick T.

Huang X.F. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 28 : 355-360 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Dalton V.S.

Long L.E.

Weickert C.S.

Zavitsanou K. Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex. Neuropsychopharmacology. 36 : 1620-1630 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Wong D.F.

Kuwabara H.

Horti A.G.

Raymont V.

Brasic J.

Guevara M.

et al. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR. Neuroimage. 52 : 1505-1513 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Wong D.F.

Kuwabara H.

Horti A.G.

Brasic J.R.

Raymont V.

Nandi A.

et al. Cannabinoid receptor subtype 1 (CB1) distribution correlates with neuropsychiatric ratings. Biol Psychiatry Abstract. 71 : 8S View in Article Google Scholar

Koethe D.

Llenos I.C.

Dulay J.R.

Hoyer C.

Torrey E.F.

Leweke F.M.

Weis S. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm. 114 : 1055-1063 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Uriguen L.

Garcia-Fuster M.J.

Callado L.F.

Morentin B.

La Harpe R.

Casado V.

et al. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: Effect of antipsychotic treatment. Psychopharmacology (Berl). 206 : 313-324 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Eggan S.M.

Mizoguchi Y.

Stoyak S.R.

Lewis D.A. Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb Cortex. 20 : 1164-1174 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Hoftman G.D.

Lewis D.A. Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: Identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull. 37 : 493-503 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Hoftman G.D.

Volk D.W.

Bazmi H.H.

Li S.

Sampson A.R.

Lewis D.A. Altered cortical expression of GABA-related genes in schizophrenia: Illness progression vs developmental disturbance. Schizophr Bull. 41 : 180-191 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Hyde T.M.

Lipska B.K.

Ali T.

Mathew S.V.

Law A.J.

Metitiri O.E.

et al. Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci. 31 : 11088-11095 View in Article Scopus (103)

PubMed

Crossref

Google Scholar

Kawamura Y.

Fukaya M.

Maejima T.

Yoshida T.

Miura E.

Watanabe M.

et al. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 26 : 2991-3001 View in Article Scopus (288)

PubMed

Crossref

Google Scholar

Eggan S.M.

Stoyak S.R.

Verrico C.D.

Lewis D.A. Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology. 35 : 2060-2071 View in Article Scopus (0)

PubMed

Crossref

Google Scholar